Skip to the page

Data / Form D filings / IceCure Medical Ltd.

IceCure Medical Ltd.: Form D filings

IceCure Medical Ltd., a biotechnology company in Caesarea, Israel, filed 3 Form D notices with the SEC between 2013 and 2026. The latest, on June 25, 2026, reports $16.5 million sold of a $16.5 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
7 HA'ESHEL STREET, Caesarea, Israel, 30795
Phone
+972.4.6230333
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Israel
Revenue range
$1,000,001 - $5,000,000
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1584371

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jun 25, 2026New notice$16,500,000$16,500,0001Jun 17, 2026sec.gov
Mar 31, 2026New notice$4,000,000$4,000,0005Mar 26, 2026sec.gov
Sep 12, 2013New notice$4,000,000$4,000,00016Aug 28, 2013sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Eyal ShamirExecutive Officer, DirectorChief Executive Officer
Meir PelegExecutive OfficerChief Financial Officer
Ron MayronDirectorChairman
Shay LevavExecutive OfficerChief Operating Officer
Tlalit Bussi Tel-TzureExecutive OfficerVice President, Business Development and Global Marketing
Merav Nir DotanExecutive OfficerVice President, Human Resources
Shad GoodExecutive OfficerVice President, Sales for North America
Vincent Chun Hung ChanDirector
Yang HuangDirector
Sharon LevitaDirector
Yonatan MalcaDirector

Every Form D from the week of Jun 22, 2026 · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what IceCure Medical Ltd. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.